News Releases Home Synthetic Biology The History of Synthetic Biology Living Medicines Designing Synthetic Biotic™ Medicines Pipeline + Programs For Patients Our People Leadership Board of Directors Founders and Advisors Join Us Investors + Media Company Overview News & Events News Releases Event Calendar Presentations & Publications Stock Information Corporate Governance Financials Investor Resources Items Per Page 102550 Year None2020201920182017201620152014 June 1, 2020 Publication in Nature Communications Highlights the Preclinical Development of SYNB1891 and its Potential as a Dual Innate Immune Activator to Stimulate an Immune Response in Difficult to Treat Tumors May 27, 2020 Synlogic Hosts First Virtual R&D Event May 21, 2020 Synlogic to Host Virtual R&D Event May 21, 2020 Synlogic Announces Termination of AbbVie Collaboration Agreement May 8, 2020 Synlogic Reports First Quarter 2020 Financial Results and Provides Business Update May 4, 2020 Synlogic Announces First Quarter 2020 Conference Call and Webcast March 30, 2020 Synlogic Provides Summary of Impact of COVID-19 on Clinical Program Progress and Operational Activities March 12, 2020 Synlogic Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update March 11, 2020 Synlogic to Present at Chardan's Virtual Microbiome Medicines Summit March 5, 2020 Synlogic Announces Fourth Quarter and Full Year 2019 Conference Call and Webcast Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last » Displaying 1 - 10 of 109 Email Alerts Contact IR RSS Feeds Print Page Email Page
Items Per Page 102550 Year None2020201920182017201620152014 June 1, 2020 Publication in Nature Communications Highlights the Preclinical Development of SYNB1891 and its Potential as a Dual Innate Immune Activator to Stimulate an Immune Response in Difficult to Treat Tumors May 27, 2020 Synlogic Hosts First Virtual R&D Event May 21, 2020 Synlogic to Host Virtual R&D Event May 21, 2020 Synlogic Announces Termination of AbbVie Collaboration Agreement May 8, 2020 Synlogic Reports First Quarter 2020 Financial Results and Provides Business Update May 4, 2020 Synlogic Announces First Quarter 2020 Conference Call and Webcast March 30, 2020 Synlogic Provides Summary of Impact of COVID-19 on Clinical Program Progress and Operational Activities March 12, 2020 Synlogic Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update March 11, 2020 Synlogic to Present at Chardan's Virtual Microbiome Medicines Summit March 5, 2020 Synlogic Announces Fourth Quarter and Full Year 2019 Conference Call and Webcast Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last » Displaying 1 - 10 of 109
June 1, 2020 Publication in Nature Communications Highlights the Preclinical Development of SYNB1891 and its Potential as a Dual Innate Immune Activator to Stimulate an Immune Response in Difficult to Treat Tumors
March 30, 2020 Synlogic Provides Summary of Impact of COVID-19 on Clinical Program Progress and Operational Activities
March 12, 2020 Synlogic Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update